zepbound and tirzepatide Zepbound® with Ivím Health's Weight Management Program Zepbound beats Wegovy for weight

Products covered on the Canadian market The Mounjaro record lists multiple Drug Identification Numbers spanning strengths of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg of tirzepatide in subcutaneous solution form [Source: dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00629]

Combined treatment with glucagon-like peptide-1 receptor agonist exendin-4 and metformin attenuates breast cancer growth

In the ATTAIN-1 trial, participants achieved a mean weight loss of 12.4% over 72 weeks. Foundayo is not yet approved or available in the UK

The Bile Acid TUDCA Increases Glucose-Induced Insulin Secretion via the cAMP/PKA Pathway in Pancreatic Beta Cells. Wilms, Britta, et al

More unburdened

Adverse events were mild and primarily gastrointestinal, such as nausea and constipation, occurring in 42% of participants